COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,722 Articles (22,502 medRxiv, 8,220 bioRxiv)

Most recent first Previous |  Page 1673: Articles 16721-16730  | Next

Mutation hotspots, geographical and temporal distribution of SARS-CoV-2 lineages in Brazil, February 2020 to February 2021: insights and limitations from uneven sequencing efforts
Franceschi, V. B., Ferrareze, P. A. G., Zimerman, R. A., Cybis, G. B., Thompson, C. E.
10.1101/2021.03.08.21253152 — Posted: 2021-03-12
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality
Nakanishi, T., Pigazzini, S., Degenhardt, F., Cordioli, M., Butler-Laporte, G., Maya-Miles, D., Nafr_a-Jim_nez, B., Bouysran, Y., Niemi, M., Palom, A., Ellinghaus, D., Khan, A., Mart_nez-Bueno, M., Rolker, S., Amitano, S., Roade, L., FinnGen, , The COVID-19 Host Genetics Initiative, , Fava, F., Spinner, C. D., Prati, D., Bernardo, D., Garcia, F., Darcis, G., Fern_ndez-Cadenas, I., Holter, J. C., Banales, J., Frithiof, R., Kiryluk, K., Duga, S., Asselta, R., Pereira, A. C., Romero-G_mez, M., Bujanda, L., Hov, J. R., Migeotte, I., Renieri, A., Planas, A. M., Ludwig, K. U., Buti, M., Rahmouni, S., Alarc_n-Riquelme, M. E., Schulte, E. C., Franke, A., Karlsen, T. H., Valenti, L., Zeberg, H., Richards, J. B., Ganna, A.
10.1101/2021.03.07.21252875 — Posted: 2021-03-12
Interventions to control nosocomial transmission of SARS-CoV-2: a modelling study
Pham, T. M., Tahir, H., van de Wijgert, J. H., Van der Roest, B., Ellerbroek, P., Bonten, M. J., Bootsma, M. C., Kretzschmar, M. E.
10.1101/2021.02.26.21252327 — Posted: 2021-03-12
Prediction of COVID-19 mortality among hospitalized patients in Sudan
Abd El-Raheem, G. O. H., Yousif, M. A. A., Mohamed, D. S. I.
10.1101/2021.03.09.21253179 — Posted: 2021-03-11
ChAdOx1 nCoV-19 (AZD1222) protects against SARS-CoV-2 B.1.351 and B.1.1.7
Fischer, R., van Doremalen, N., Adney, D., Yinda, C., Port, J., Holbrook, M., Schulz, J., Williamson, B., Thomas, T., Barbian, K., Anzick, S., Ricklefs, S., Smith, B., Long, D., Martens, C., Saturday, G., de Wit, E., Gilbert, S., Lambe, T., Munster, V.
10.1101/2021.03.11.435000 — Posted: 2021-03-11
Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications
Shen, L., Dien Bard, J., Triche, T. J., Judkins, A. R., Biegel, J. A., Gai, X.
10.1101/2021.03.11.434758 — Posted: 2021-03-11
Phodopus roborovskii SH101 as a systemic infection model of SARS-CoV-2
Zhai, C., Wang, M., Chung, H.-J., Hassan, M. M., Lee, S., Kim, H.-J., Hong, S.-T.
10.1101/2021.03.10.434891 — Posted: 2021-03-11
In vitro and in vivo preclinical studies predict REGEN-COV protection against emergence of viral escape in humans
Copin, R., Baum, A., Wloga, E., Pascal, K. E., Giordano, S., Fulton, B. O., Zhou, A., Negron, N., Lanza, K., Chan, N., Coppola, A., Chiu, J., Ni, M., Atwal, G. S., Romero Hernandez, A., Saotome, K., Zhou, Y., Franklin, M. C., Hooper, A. T., McCarthy, S., Hamon, S., Hamilton, J. D., Staples, H. M., Alfson, K., Carrion, R., Ali, S., Norton, T., Somersan-Karakaya, S., Sivapalasingam, S., Herman, G. A., Weinreich, D. M., Lipsich, L., Stahl, N., Murphy, A. J., Yancopoulos, G. D., Kyratsous, C. A.
10.1101/2021.03.10.434834 — Posted: 2021-03-11
Low ozone concentration and negative ions for rapid SARS-CoV-2 inactivation
De Forni, D., Poddesu, B., Cugia, G., Gallizia, G., La Licata, M., Lisziewicz, J., Chafouleas, J. G., Lori, F.
10.1101/2021.03.11.434968 — Posted: 2021-03-11
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-CoV-2 Infection in vitro
Gilham, D., Smith, A. L., Fu, L., Moore, D. Y., Muralidharan, A., Reid, S. P. M., Stotz, S. C., Johansson, J. O., Sweeney, M., Wong, N. C., Kulikowski, E., El-Gamal, D.
10.1101/2021.03.10.432949 — Posted: 2021-03-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).